Table 1.
NSAIDs | SSRI, corticosteroids | Increased bleeding risk (especially in the gastrointestinal tract) |
In combination with ACE inhibitors risk of renal failure | Risk of renal failure | |
With antidepressants, anticonvulsants, antipsychotics and opioids | Increased electrolyte imbalance like hyponatremia | |
Paracetamol | With 5‑HT3 antagonists (e.g. ondansetron or tropisetron) | Reduction of analgesic efficacy |
Antidepressants | – | Increased incidence of arrhythmia in patients with cardiac impairments |
Gabapentin | With antacids | Reduced resorption (at least 2‑h intervals between doses) |
Pregabalin | With oxycodone | Possible impairment of cognitive and gross motor skills |
NSAID nonsteroidal anti-inflammatory drugs, SSRI Selective Serotonin Reuptake Inhibitors